Cargando…
Treatment Individualization in Colorectal Cancer
Colorectal cancer has been characterized as a genetically heterogeneous disease, with a large diversity in molecular pathogenesis resulting in differential responses to therapy. However, the currently available validated biomarkers KRAS, BRAF, and microsatellite instability do not sufficiently cover...
Autores principales: | van Geel, Robin M. J. M., Beijnen, Jos H., Bernards, René, Schellens, Jan H.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653238/ https://www.ncbi.nlm.nih.gov/pubmed/26617477 http://dx.doi.org/10.1007/s11888-015-0288-z |
Ejemplares similares
-
Pulmonary Metastasectomy for Colorectal Cancer: Recent Reports Prompt a Review of the Available Evidence
por: Treasure, Tom
Publicado: (2014) -
Improved Postoperative Outcomes after Prehabilitation for Colorectal Cancer Surgery in Older Patients: An Emulated Target Trial
por: Heil, Thea C., et al.
Publicado: (2022) -
Using CT colonography as a triage technique after a positive faecal occult blood test in colorectal cancer screening
por: Liedenbaum, M H, et al.
Publicado: (2009) -
Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition
por: Fujisawa, T, et al.
Publicado: (2008) -
Lymph Node Negative Colorectal Cancers with Isolated Tumor Deposits Should Be Classified and Treated As Stage III
por: Belt, E. J. Th., et al.
Publicado: (2010)